Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2021 1
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean n anghel (85 results)?
Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry.
Nowatzke J, Guedeney P, Palaskas N, Lehmann L, Ederhy S, Zhu H, Cautela J, Francis S, Courand PY, Deswal A, Ewer SM, Aras M, Arangalage D, Ghafourian K, Fenioux C, Finke D, Peretto G, Zaha V, Itzhaki Ben Zadok O, Tajiri K, Akhter N, Levenson J, Baldassarre L, Power J, Huang S, Collet JP, Moslehi J, Salem JE; International ICI-myocarditis registry contributors. Nowatzke J, et al. Eur J Cancer. 2022 Dec;177:197-205. doi: 10.1016/j.ejca.2022.07.018. Epub 2022 Aug 24. Eur J Cancer. 2022. PMID: 36030143 Free PMC article.
The cardiovascular effects of gonadotropin-releasing hormone antagonists in men with prostate cancer.
Cirne F, Aghel N, Petropoulos JA, Klotz L, Lenihan DJ, Saad F, Pinthus J, Leong DP. Cirne F, et al. Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):253-262. doi: 10.1093/ehjcvp/pvab005. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 33470403
We identified 10 eligible studies including two different GnRH antagonists, degarelix (n = 1681) and relugolix (n = 734), which were compared with the GnRH agonists, leuprolide (n = 714) and goserelin (n = 600). ...
We identified 10 eligible studies including two different GnRH antagonists, degarelix (n = 1681) and relugolix (n = 734), whic …
Tyrosine kinase inhibitors in chronic myeloid leukaemia and emergent cardiovascular disease.
Leong D, Aghel N, Hillis C, Siegal D, Karampatos S, Rangarajan S, Pond G, Seow H. Leong D, et al. Heart. 2021 Apr;107(8):667-673. doi: 10.1136/heartjnl-2020-318251. Epub 2021 Jan 8. Heart. 2021. PMID: 33419879
METHODS: A population-based retrospective study including all patients (n=4238) diagnosed with CML in Ontario, Canada between 1986 and 2017 and and age-matched and sex-matched individuals who received healthcare but who did not have CML (controls: n=42 380). ...
METHODS: A population-based retrospective study including all patients (n=4238) diagnosed with CML in Ontario, Canada between 1986 an …